Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risenex Plus M in Postmenopausal Osteoporosis
NCT01806792Phase 3Completed
- Sponsor
- Hanlim Pharm
- Start
- Nov 2009
- Primary completion
- Aug 2010
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of vitamin d in postmenopausal osteoporosis, sponsored by Hanlim Pharm. Started Nov 2009; status: completed.
02
Drugs
vitamin d
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT01806792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01806792.